NI
BIVV

Numeric Investors’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Numeric Investors’s Portfolio BIVV Stock Details BIVV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$12.2M Buy
226,200
+163,300
+260% +$8.93M 0.09% 216
2017
Q3 		$3.59M Buy
62,900
+55,300
+728% +$3.24M 0.03% 475
2017
Q2 		$457K Sell
7,600
-23,855
-76% -$1.36M ﹤0.01% 845
2017
Q1 		$1.71M Buy
+31,455
New +$1.55M 0.02% 515

Other funds holding BIVV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JIM
Jupiter Investment Management London, United Kingdom $6.26B AUM 13.19% 1-Year Est. Return

Numeric Investors's BIVV Position: Q4 2017 in Review

Numeric Investors increased its Bioverativ Inc. Common Stock (BIVV) stake by 260% in Q4 2017, buying an estimated $8.93M and bringing the position to 226,200 shares worth $12.2M. The position accounts for 0.09% of the portfolio, ranked #216.

Numeric Investors first reported a position in BIVV in Q1 2017 and has held it in 4 quarters since. 459 funds tracked by Wall St. Rank hold BIVV as of Q4 2017.

  • Numeric Investors held 226,200 shares of Bioverativ Inc. Common Stock worth $12.2M as of Q4 2017.
  • Numeric Investors bought 163,300 Bioverativ Inc. Common Stock shares in Q4 2017, an estimated $8.93M.
  • Bioverativ Inc. Common Stock made up 0.09% of Numeric Investors's portfolio in Q4 2017, its #216 holding.
  • Numeric Investors first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and has held it in 4 quarters since.
  • 459 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q4 2017.

Based on Numeric Investors's 13F filing for Q4 2017, filed 14 Feb 2018.